Home › Funds › PNC Financial Services › VRTX
PNC Financial Services position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)69.36K sh
Reported value held$34.45M
Portfolio Weight0.02%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 31.14K | $5.65M | New |
| Q4 2021 | 51.54K | $11.32M | Add |
| Q1 2022 | 71.16K | $18.57M | Add |
| Q2 2022 | 71.36K | $20.11M | Hold |
| Q3 2022 | 72.60K | $21.02M | Add |
| Q4 2022 | 70.28K | $20.29M | Reduce |
| Q1 2023 | 68.21K | $21.49M | Reduce |
| Q2 2023 | 72.69K | $25.58M | Add |
| Q3 2023 | 74.27K | $25.82M | Add |
| Q4 2023 | 76.70K | $31.21M | Add |
| Q1 2024 | 79.95K | $33.42M | Add |
| Q2 2024 | 75.16K | $35.23M | Reduce |
| Q3 2024 | 79.43K | $36.94M | Add |
| Q4 2024 | 78.62K | $31.66M | Reduce |
| Q1 2025 | 78.16K | $37.89M | Reduce |
| Q2 2025 | 76.16K | $33.90M | Reduce |
| Q3 2025 | 69.77K | $27.33M | Reduce |
| Q4 2025 | 69.42K | $31.47M | Hold |
| Q1 2026 | 71.94K | $32.12M | Add |
| Q2 2026 | 69.36K | $34.45M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026